Personalized Health Basel (PHB) aims to develop and promote Personalized Health for the benefit of patients, research and society.
By harmonizing existing processes, building new information technology (IT) and biobanking infrastructures, and by forming national and international research collaborations we will consolidate the Basel area as a hub of research excellence and a place where people benefit from personalized healthcare.
Our activities are closely coordinated with our partners in Zurich within the Personalized Health Alliance Zurich-Basel. Our goal is to participate in initiatives of the Swiss Personalized Health Network (SPHN).
Venue: Conference Center Basel, Switzerland
Dates: Monday January 20th - Tuesday January 21st, 2020
Registration: Early bird registration now open here!
Call for Abstracts: Submit your research abstract for selection for a poster session (submit by October 15). Details here.
This conference will enhance your insights of digitalization, machine learning and personalized health in infectious diseases. Most recent breakthroughs and translation into applications to clinics will be shown and discussed. Join the key opinion leaders in these fields and build your network with experts in information technology, machine learning and big data, clinical microbiology, infectious diseases, biomedical research, law and ethics, and more.
For details please visit the conference website
Scientific exchange has to be fostered during this difficult period with travel and meeting restrictions. Therefore Personalized Health Technologies 2020 will be a virtual-only conference. The event takes place 29 & 30 June 2020 and is organized by the ETH Zurich Technology Platform NEXUS Personalized Health Technologies.
The next steps in personalized health. This conference brings together experts from multiple disciplines to explore present and future directions in the field of personalized health technologies and translational research. The goal is to tackle challenges in chemical hit identification, lead development, molecular circuit analyses, clinical bioinformatics, and multivariate statistics, as well as their clinical application.
From patient samples to molecular read outs. Progress in the laboratory representation of clinical material has enabled novel possibilities for discovery and diagnostics with thus far unrivaled proximity to the patient. Advanced cell systems such as organoids allow for in-depth molecular profiling and functional studies as well as investigation of responses to chemical and therapeutic agents. Combined with high-throughput screening and chemical biology, empirical projects of very large scope have not only become conceivable but also present themselves with feasible turnaround time.
Integration of molecular modalities and global knowledge. The continuous development of next-generation sequencing and mass spectrometry measurements allow for high-resolution characterization of biomolecules derived from patient samples or mouse models of disease. While early challenges of storage and compute capacity have largely been addressed, present ones are the integration and combined analysis of multifaceted data, including public online resources.
For more information please visit the website
October 22nd, 2020 at the Geneva School of Business Administration (HEG/HES-SO)!
The event focuses on all aspects of Research Data Management (RDM). It offers a discussion space to exchange on major challenging technologies and approaches that characterize the RDM practices from the researcher's perspective as well as from the institutional point of view.
EMERGENT APPROACHES FOR OPEN SCIENCE
This year's special focus is the double perspective of Open Science and emerging approaches. The event brings together an interdisciplinary community of researchers, librarians, funders, publishers and policy-makers, providing a critical look at the new developments in RDM practices, standards and technologies.
The agenda will feature keynote presentations, workshops and panel discussions.
CALL FOR PAPERS FOR #SRDD2020
For this edition, we invite you to share your recent studies and innovative initiatives related to RDM. What are today’s solutions? What will the future be like?
Topics of interest include, but are not limited to: emergent technologies in RDM and artificial intelligence, practical, ethical and legal aspects of RDM, research data and Open Science, research data quality assessment, and Data Management Plans (DMPs).
More information on the website
A flourishing research hub needs adequate infrastructure at its foundation. PHB has defined four areas to be further developed: Clincal Data Warehouse, Biobanking, Clinical Bioinformatics, and Ethical – Legal – Societal Implications (ELSI). To ensure the infrastructure follows the needs of the science, the three research focus areas "Oncology", "Immunology", and "Infectious Diseases" will run first projects on the new platform. At the same time we work on interoperability in the same infrastructure and research focus areas with our partners of the PH-Alliance Zurich-Basel. For nation-wide data sharing and research we participate in the Swiss Personalized Health Network (SPHN).
Head Department of Clinical Research
Head Department of Clinical Research / Head Clinical Trial Unit
Clinical Director University Children’s Hospital Basel
Personalized Health Manager
Coordinator PHB Research Clusters
Personalized Health Manager